25.10.2018 13:42:03

Celgene Corporation Q3 adjusted earnings Beat Estimates

(RTTNews) - Celgene Corporation (CELG) reported a profit for its third quarter that advanced from the same period last year.

The company's bottom line came in at $1.08 billion, or $1.50 per share. This compares with $0.99 billion, or $1.21 per share, in last year's third quarter.

Excluding items, Celgene Corporation reported adjusted earnings of $1.65 billion or $2.29 per share for the period.

Analysts had expected the company to earn $2.22 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 18.2% to $3.89 billion from $3.29 billion last year.

Celgene Corporation earnings at a glance:

-Earnings (Q3): $1.65 Bln. vs. $1.56 Bln. last year. -EPS (Q3): $2.29 vs. $1.91 last year. -Analysts Estimate: $2.22 -Revenue (Q3): $3.89 Bln vs. $3.29 Bln last year.

-Guidance: Full year EPS guidance: $8.75 - $8.80 Full year revenue guidance: $15.2 Bln

Nachrichten zu Celgene Corp.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Celgene Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!